{"id":"https://openalex.org/W2310066077","doi":"https://doi.org/10.1093/neuonc/nov208.37","title":"BMET-37PHASE I STUDY OF AZD3759, AN EGFR INHIBITOR WITH BLOOD BRAIN BARRIER (BBB) PENETRATION, FOR THE TREATMENT OF EGFRm+ NON-SMALL CELL LUNG CANCER (NSCLC) WITH BRAIN METASTASIS AND LEPTOMENGINGEAL METASTASIS","display_name":"BMET-37PHASE I STUDY OF AZD3759, AN EGFR INHIBITOR WITH BLOOD BRAIN BARRIER (BBB) PENETRATION, FOR THE TREATMENT OF EGFRm+ NON-SMALL CELL LUNG CANCER (NSCLC) WITH BRAIN METASTASIS AND LEPTOMENGINGEAL METASTASIS","publication_year":2015,"publication_date":"2015-11-01","ids":{"openalex":"https://openalex.org/W2310066077","doi":"https://doi.org/10.1093/neuonc/nov208.37","mag":"2310066077"},"language":"en","primary_location":{"id":"doi:10.1093/neuonc/nov208.37","doi":"https://doi.org/10.1093/neuonc/nov208.37","is_oa":false,"landing_page_url":"https://doi.org/10.1093/neuonc/nov208.37","pdf_url":null,"source":{"id":"https://openalex.org/S106908163","display_name":"Neuro-Oncology","issn_l":"1522-8517","issn":["1522-8517","1523-5866"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-b","doyens","jufo-2","ki-jl-2","medline","norway-2","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310311648","host_organization_name":"Oxford University Press","host_organization_lineage":["https://openalex.org/P4310311648","https://openalex.org/P4310311647"],"host_organization_lineage_names":["Oxford University Press","University of Oxford"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Neuro-Oncology","raw_type":"journal-article"},"volume":null,"type":"article","indexed_in":["crossref"],"open_access":{"is_oa":true,"oa_status":"green","oa_url":"https://www.ncbi.nlm.nih.gov/pmc/articles/4638639","any_repository_has_fulltext":true},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5034739279","display_name":"Myung\u2010Ju Ahn","orcid":"https://orcid.org/0000-0002-5740-9654","observed_orcids":["https://orcid.org/0000-0002-5740-9654","https://orcid.org/0000-0002-5376-5109"]},"institutions":[{"id":"https://openalex.org/I2802194831","display_name":"Samsung Medical Center","ror":"https://ror.org/05a15z872","country_code":"KR","type":"healthcare","lineage":["https://openalex.org/I2250650973","https://openalex.org/I2802194831"]}],"countries":["KR"],"is_corresponding":false,"raw_author_name":"Myung-Ju Ahn","raw_affiliation_strings":["Samsung Medical Center, Seoul, Republic of Korea"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Samsung Medical Center, Seoul, Republic of Korea","institution_ids":["https://openalex.org/I2802194831"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5100638261","display_name":"Dong\u2010Wan Kim","orcid":"https://orcid.org/0000-0001-5124-7132","observed_orcids":["https://orcid.org/0000-0001-5124-7132"]},"institutions":[{"id":"https://openalex.org/I2802835388","display_name":"Seoul National University Hospital","ror":"https://ror.org/01z4nnt86","country_code":"KR","type":"healthcare","lineage":["https://openalex.org/I139264467","https://openalex.org/I2802835388"]}],"countries":["KR"],"is_corresponding":false,"raw_author_name":"Dong-Wan Kim","raw_affiliation_strings":["Seoul National University Hospital, Seoul, Republic of Korea"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Seoul National University Hospital, Seoul, Republic of Korea","institution_ids":["https://openalex.org/I2802835388"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5023226614","display_name":"Paul Mart\u00edn","orcid":"https://orcid.org/0000-0002-2029-9359","observed_orcids":["https://orcid.org/0000-0002-2029-9359"]},"institutions":[{"id":"https://openalex.org/I105036370","display_name":"AstraZeneca (United Kingdom)","ror":"https://ror.org/04r9x1a08","country_code":"GB","type":"company","lineage":["https://openalex.org/I105036370"]}],"countries":["GB"],"is_corresponding":false,"raw_author_name":"Paul Martin","raw_affiliation_strings":["Early Clinical Development, AstraZeneca, Cambridge, UK"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Early Clinical Development, AstraZeneca, Cambridge, UK","institution_ids":["https://openalex.org/I105036370"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5057436507","display_name":"Chris Davison","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I105036370","display_name":"AstraZeneca (United Kingdom)","ror":"https://ror.org/04r9x1a08","country_code":"GB","type":"company","lineage":["https://openalex.org/I105036370"]}],"countries":["GB"],"is_corresponding":false,"raw_author_name":"Chris Davison","raw_affiliation_strings":["Early Clinical Development, AstraZeneca, Cambridge, UK"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Early Clinical Development, AstraZeneca, Cambridge, UK","institution_ids":["https://openalex.org/I105036370"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5038613600","display_name":"Zhenfan Yang","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Zhenfan Yang","raw_affiliation_strings":["Innovation Center China, Asia & Emerging Markets IMED, AstraZeneca, Shanghai, China"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Innovation Center China, Asia & Emerging Markets IMED, AstraZeneca, Shanghai, China","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5061878462","display_name":"Haiyi Jiang","orcid":"https://orcid.org/0009-0002-8677-6821","observed_orcids":["https://orcid.org/0009-0002-8677-6821"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Haiyi Jiang","raw_affiliation_strings":["Global Medicine Development, AstraZeneca, Shanghai, China"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Global Medicine Development, AstraZeneca, Shanghai, China","institution_ids":[]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5055074037","display_name":"James Chih\u2010Hsin Yang","orcid":"https://orcid.org/0000-0002-5586-5138","observed_orcids":["https://orcid.org/0000-0002-5586-5138"]},"institutions":[{"id":"https://openalex.org/I4210131804","display_name":"National Taiwan University Hospital","ror":"https://ror.org/03nteze27","country_code":"TW","type":"healthcare","lineage":["https://openalex.org/I4210131804"]}],"countries":["TW"],"is_corresponding":false,"raw_author_name":"James Chih-Hsin Yang","raw_affiliation_strings":["National Taiwan University Hospital, Taipei, Taiwan"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"National Taiwan University Hospital, Taipei, Taiwan","institution_ids":["https://openalex.org/I4210131804"]}]}],"institutions":[],"countries_distinct_count":3,"institutions_distinct_count":4,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":{"value":5132,"currency":"USD","value_usd":5132},"apc_paid":null,"fwci":0.0,"has_fulltext":false,"cited_by_count":0,"citation_normalized_percentile":{"value":0.2056463,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":null,"biblio":{"volume":"17","issue":"suppl 5","first_page":"v53.2","last_page":"v53"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10417","display_name":"Lung Cancer Treatments and Mutations","score":0.9258000254631042,"subfield":{"id":"https://openalex.org/subfields/2740","display_name":"Pulmonary and Respiratory Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10417","display_name":"Lung Cancer Treatments and Mutations","score":0.9258000254631042,"subfield":{"id":"https://openalex.org/subfields/2740","display_name":"Pulmonary and Respiratory Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11600","display_name":"Brain Metastases and Treatment","score":0.0674000009894371,"subfield":{"id":"https://openalex.org/subfields/2740","display_name":"Pulmonary and Respiratory Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10755","display_name":"HER2/EGFR in Cancer Research","score":0.0003000000142492354,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/egfr-inhibitors","display_name":"EGFR inhibitors","score":0.8320000171661377},{"id":"https://openalex.org/keywords/egfr-mutant-non-small-cell-lung-cancer","display_name":"EGFR-mutant non-small cell lung cancer","score":0.8889999985694885},{"id":"https://openalex.org/keywords/brain-metastases","display_name":"brain metastases","score":0.9739999771118164},{"id":"https://openalex.org/keywords/leptomeningeal-metastasis","display_name":"leptomeningeal metastasis","score":1.0},{"id":"https://openalex.org/keywords/blood-brain-barrier-penetration","display_name":"blood-brain barrier penetration","score":0.9950000047683716},{"id":"https://openalex.org/keywords/maximum-tolerated-dose","display_name":"maximum tolerated dose","score":0.765999972820282},{"id":"https://openalex.org/keywords/safety-and-tolerability","display_name":"safety and tolerability","score":0.7089999914169312},{"id":"https://openalex.org/keywords/central-nervous-system-metastases","display_name":"central nervous system metastasis","score":0.6809999942779541},{"id":"https://openalex.org/keywords/tyrosine-kinase-inhibitors","display_name":"tyrosine kinase inhibitors","score":0.7279999852180481},{"id":"https://openalex.org/keywords/dose-escalation","display_name":"dose escalation","score":0.40700000524520874},{"id":"https://openalex.org/keywords/egfr-phosphorylation","display_name":"EGFR phosphorylation","score":0.5559999942779541}],"concepts":[{"id":"https://openalex.org/C2778164965","wikidata":"https://www.wikidata.org/wiki/Q1620196","display_name":"Brain metastasis","level":4,"score":0.7589290142059326},{"id":"https://openalex.org/C2778402981","wikidata":"https://www.wikidata.org/wiki/Q221694","display_name":"Blood\u2013brain barrier","level":3,"score":0.7220336198806763},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.647040843963623},{"id":"https://openalex.org/C2776256026","wikidata":"https://www.wikidata.org/wiki/Q47912","display_name":"Lung cancer","level":2,"score":0.5720329880714417},{"id":"https://openalex.org/C2779013556","wikidata":"https://www.wikidata.org/wiki/Q181876","display_name":"Metastasis","level":3,"score":0.48184335231781006},{"id":"https://openalex.org/C502942594","wikidata":"https://www.wikidata.org/wiki/Q3421914","display_name":"Cancer research","level":1,"score":0.4429388642311096},{"id":"https://openalex.org/C80107235","wikidata":"https://www.wikidata.org/wiki/Q7162625","display_name":"Penetration (warfare)","level":2,"score":0.4226279854774475},{"id":"https://openalex.org/C143998085","wikidata":"https://www.wikidata.org/wiki/Q162555","display_name":"Oncology","level":1,"score":0.4037597179412842},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.3213362693786621},{"id":"https://openalex.org/C121608353","wikidata":"https://www.wikidata.org/wiki/Q12078","display_name":"Cancer","level":2,"score":0.23209336400032043},{"id":"https://openalex.org/C529278444","wikidata":"https://www.wikidata.org/wiki/Q47273","display_name":"Central nervous system","level":2,"score":0.13373792171478271},{"id":"https://openalex.org/C127413603","wikidata":"https://www.wikidata.org/wiki/Q11023","display_name":"Engineering","level":0,"score":0.0},{"id":"https://openalex.org/C42475967","wikidata":"https://www.wikidata.org/wiki/Q194292","display_name":"Operations research","level":1,"score":0.0}],"mesh":[],"locations_count":2,"locations":[{"id":"doi:10.1093/neuonc/nov208.37","doi":"https://doi.org/10.1093/neuonc/nov208.37","is_oa":false,"landing_page_url":"https://doi.org/10.1093/neuonc/nov208.37","pdf_url":null,"source":{"id":"https://openalex.org/S106908163","display_name":"Neuro-Oncology","issn_l":"1522-8517","issn":["1522-8517","1523-5866"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-b","doyens","jufo-2","ki-jl-2","medline","norway-2","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310311648","host_organization_name":"Oxford University Press","host_organization_lineage":["https://openalex.org/P4310311648","https://openalex.org/P4310311647"],"host_organization_lineage_names":["Oxford University Press","University of Oxford"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Neuro-Oncology","raw_type":"journal-article"},{"id":"pmh:oai:pubmedcentral.nih.gov:4638639","doi":null,"is_oa":true,"landing_page_url":"https://www.ncbi.nlm.nih.gov/pmc/articles/4638639","pdf_url":null,"source":{"id":"https://openalex.org/S2764455111","display_name":"PubMed Central","issn_l":null,"issn":null,"is_oa":true,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Neuro Oncol","raw_type":"Text"}],"best_oa_location":{"id":"pmh:oai:pubmedcentral.nih.gov:4638639","doi":null,"is_oa":true,"landing_page_url":"https://www.ncbi.nlm.nih.gov/pmc/articles/4638639","pdf_url":null,"source":{"id":"https://openalex.org/S2764455111","display_name":"PubMed Central","issn_l":null,"issn":null,"is_oa":true,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Neuro Oncol","raw_type":"Text"},"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","score":1.0,"display_name":"Good health and well-being"}],"study_designs":[{"id":"https://openalex.org/study-designs/clinical-trial","display_name":"Clinical Trial"}],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W2673709515","https://openalex.org/W2512939901","https://openalex.org/W2560000670","https://openalex.org/W2614546142","https://openalex.org/W2727135362","https://openalex.org/W2765641949","https://openalex.org/W4377993456","https://openalex.org/W2484897859","https://openalex.org/W4379280951","https://openalex.org/W2789249188"],"abstract_inverted_index":{"BACKGROUND:":[0],"EGFRm+":[1,86,126,188,273],"NSCLC":[2,87,127,274],"with":[3,35,85,90,123,194,223,237,265,269,276],"central":[4],"nervous":[5],"system":[6],"(CNS)":[7],"metastases,":[8],"including":[9],"BM":[10,51,157,277],"(brain":[11],"metastasis)":[12],"and":[13,52,79,93,115,141,149,158,163,278,286],"LM":[14,53],"(leptomeningeal":[15],"metastasis),":[16],"has":[17],"high":[18],"unmet":[19],"medical":[20],"need":[21],"due":[22],"to":[23,76,102,216,271],"lack":[24],"of":[25,60,81,152,169,176,196,245],"effective":[26],"treatment.":[27],"We":[28],"discovered":[29],"AZD3759,":[30],"an":[31,63,71,262],"oral":[32],"EGFR":[33,42,91,199,263],"inhibitor":[34],"better":[36],"BBB":[37,267],"penetration":[38,268],"than":[39],"other":[40],"available":[41],"TKIs,":[43],"which":[44],"demonstrates":[45],"profound":[46],"anti-tumor":[47],"effect":[48],"in":[49,62,83,98,134,138,143,187,230,247,250,293],"preclinical":[50],"models.":[54],"Here":[55],"we":[56],"present":[57],"preliminary":[58,116],"data":[59],"AZD3759":[61,82,170,260],"ongoing":[64,285],"phase":[65,111,281],"I":[66],"study.":[67],"METHODS:":[68],"This":[69,95],"is":[70,261,284],"open":[72],"label,":[73],"multi-center":[74],"study":[75,100,132,283],"assess":[77],"safety":[78],"tolerability":[80],"patients":[84,122,154,179,201,222,236,275],"who":[88],"progressed":[89],"TKI":[92,264],"chemotherapy.":[94],"First":[96],"Time":[97],"Human":[99],"aims":[101],"determine":[103],"the":[104,131,174,220,231,294],"maximal":[105],"tolerated":[106],"dose":[107,113,175,211],"(MTD)":[108],"and/or":[109,205],"recommended":[110],"II":[112],"(RP2D)":[114],"efficacy.":[117],"RESULTS:":[118],"To":[119],"date,":[120],"17":[121,153],"advanced":[124],"stage":[125],"were":[128,192,214],"enrolled":[129],"into":[130],"(5":[133,200],"50mg":[135],"bid,":[136],"7":[137],"100mg":[139],"bid":[140,145],"5":[142],"200mg":[144],"cohorts,":[146],"respectively).":[147],"11":[148],"2":[150,234],"out":[151],"have":[155],"measurable":[156,224],"LM,":[159,238],"respectively.":[160],"Dose-dependent":[161],"plasma":[162],"CSF":[164,181],"(cerebral":[165],"spinal":[166],"fluid)":[167],"exposure":[168],"was":[171],"observed.":[172],"At":[173],"200mg,":[177],"all":[178],"had":[180],"Ctrough":[182],"concentration":[183],"above":[184],"pEGFR":[185,246],"IC50":[186],"cells.":[189],"Adverse":[190],"events":[191],"consistent":[193],"inhibition":[195],"wild":[197],"type":[198],"experienced":[202],"skin":[203],"rash":[204],"diarrhea,":[206],"mainly":[207],"grade":[208],"1).":[209],"No":[210],"limiting":[212],"toxicities":[213],"observed":[215],"date.":[217],"In":[218,233],"16":[219],"evaluable":[221,235],"BM,":[225],"4":[226],"showed":[227,241],"tumor":[228,248],"shrinkage":[229],"brain.":[232],"1":[239,282],"patient":[240],"a":[242],"94%":[243],"reduction":[244],"cells":[249],"CSF,":[251],"determined":[252],"by":[253],"\"H\"":[254],"score":[255],"using":[256],"immunohistochemistry":[257],"assay.":[258],"CONCLUSION:":[259],"good":[266],"potential":[270],"treat":[272],"LM.":[279],"The":[280],"updated":[287],"clinical":[288],"results":[289],"will":[290],"be":[291],"presented":[292],"meeting.":[295]},"counts_by_year":[],"updated_date":"2026-10-27T15:51:10.671819","created_date":"2016-06-24T00:00:00"}